Insulin resistance determines efficacy of glimepiride in Type 2 diabetic patients not well controlled by diet alone.
Shimizu
Hiroyuki
H
Monden
Takeshi
T
Nagai
Takashi
T
Shoda
Yoshihito
Y
Sato
Tetsurou
T
Yamada
Masanobu
M
Mori
Masatomo
M
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D016896:Treatment Outcome
D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; C057619:glimepiride